Lingling Si
Impact in
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Natural product bioactivities and synthesis 3
- Mitochondrial Function and Pathology 3
-
- Cancer Research and Treatments 2
- Microbial Metabolism and Applications 2
- Co-authors
- Toshihiko Hayashi (4 shared papers)Takashi Ikejima (4 shared papers)Weiwei Liu (4 shared papers)Satoshi Onodera (4 shared papers)Qiusheng Zheng (6 shared papers)Shunji Hattori (3 shared papers)Kazunori Mizuno (3 shared papers)Xinyan Yan (4 shared papers)
- Journals
- Archives of Biochemistry and Biophysics (3 papers)Recent Patents on Anti-Cancer Drug Discovery (2 papers)British Journal of Pharmacology (1 paper)Frontiers in Oncology (1 paper)Molecular Therapy — Oncolytics (1 paper)
- Partner nations
- ChinaUnited KingdomJapan
In The Last Decade
Lingling Si
17 papers receiving 431 citations
Peers
Comparison fields: 5 of 63
- Pharmacology 71
- Cancer Research 94
- Molecular Biology 298
- Toxicology 13
- Biochemistry 17
Countries citing papers authored by Lingling Si
This map shows the geographic impact of Lingling Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Si more than expected).
Fields of papers citing papers by Lingling Si
This network shows the impact of papers produced by Lingling Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Si. The network helps show where Lingling Si may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingling Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 90 | |
| 2 | 2016 | 56 | |
| 3 | 2017 | 56 | |
| 4 | 2019 | 36 | |
| 5 | 2016 | 35 | |
| 6 | 2018 | 28 | |
| 7 | 2017 | 26 | |
| 8 | 2020 | 24 | |
| 9 | 2022 | 20 | |
| 10 | 2018 | 14 | |
| 11 | 2020 | 12 | |
| 12 | 2018 | 12 | |
| 13 | 2023 | 11 | |
| 14 | 2025 | 6 | |
| 15 | 2020 | 5 | |
| 16 | 2022 | 2 | |
| 17 | 2025 | 1 |
About Lingling Si
Lingling Si is a scholar working on Molecular Biology, Biotechnology, Genetics, Oncology and Pharmacology, having authored 17 papers that have together received 434 indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (3 papers), Virus-based gene therapy research (3 papers), CAR-T cell therapy research (3 papers), Pharmacological Effects of Natural Compounds (3 papers), Mitochondrial Function and Pathology (3 papers), Cancer Research and Treatments (2 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Microbial Metabolism and Applications (2 papers). The work is most often cited by research in Pharmacology (71 citations), Cancer Research (94 citations), Molecular Biology (298 citations), Toxicology (13 citations) and Biochemistry (17 citations). Lingling Si has collaborated with scholars based in China, United Kingdom and Japan. Frequent co-authors include Toshihiko Hayashi, Takashi Ikejima, Weiwei Liu, Satoshi Onodera, Qiusheng Zheng, Shunji Hattori, Kazunori Mizuno, Xinyan Yan, Yan Qi and Lina Xu. Their work appears in journals such as Archives of Biochemistry and Biophysics, Recent Patents on Anti-Cancer Drug Discovery, British Journal of Pharmacology, Frontiers in Oncology and Molecular Therapy — Oncolytics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.